UK Investor Magazine

Eden BioSolutions (LON: EDEN) has been granted an unconditional registration by the US authorities for Mevalone Delta, an optimised biofungicide formulation based upon Eden’s registered active ingredients and microencapsulation technology, Sustaine®. The addressable market in the US is estimated to be $114m. The share price gained 21% to 3.75p. Ore sorting tests by Rockfire R...

The FTSE 100 was steady Friday as investors assessed the implications of Nvidia’s CEO’s sacking and potential ramifications for the global AI trade and the wider economy. After a rollercoaster week for US technology shares, futures pointed to a benign session later today, perhaps reflecting fatigue from a week of unexpected events with no playbook. […]

The post

Aviva delivered a strong third quarter, with its general insurance and wealth arms driving growth and the insurer reaffirming its three-year financial targets. The update was well-received, and Aviva shares rose 2% in early trading. General insurance premiums rose 19% to £11.8bn, with UK and Ireland up 27%, driven by the acquisition of Direct Line […]

The post

Rockfire Resources said early ore-sorting tests have increased the zinc grade of ore from its Molaoi project in Greece, supporting the case for adding a sorting stage to the mine’s future processing design. This is the kind of news investors have been hoping for. The tests, run by specialist TOMRA, used X-ray sorting technology to […]

The post

The FTSE 100 rose on Thursday as investors focused on a raft of strong updates from UK companies including Persimmon, Rolls-Royce and Burberry. UK corporate updates were a welcome distraction from the soap opera that is the scandal surrounding the Nvidia boss’s extramarital affairs. The Nvidia board are reportedly meeting to arrange the ousting of […]

The post